Category: St. Jude Medical
St. Jude Medical champions the data behind the pre-market approval study for its Trifecta heart valve.
St. Jude Medical
St. Jude Medical (NYSE:STJ) championed newly published results from the 4-year-old study it used to back its pre-market approval application for the Trifecta heart valve in The Journal of Thoracic and Cardiovascular Surgery.
Medtronic CFO Gary Ellis tells investors that the CRM market has stabilized, but the industry faces a new baseline of flat to low single-digit growth in established markets.
The U.S. market for pacemakers and implantable cardioverter-defibrillators remains tepid and unlikely to return to previous levels of growth, according to Medtronic (NYSE:MDT) CFO Gary Ellis.
Medical device company St. Jude Medical enrolls the 1st patient in the pivotal phase of its Amplatzer Cardiac Plug clinical trial, comparing the stroke prevention device to long-term drug therapy.
Medical device giant St. Jude Medical (NYSE:STJ) enrolled the 1st patient in the pivotal phase of its Amplatzer Cardiac Plug clinical trial, which will compare the company's Amplatzer device to long-term treatment with blood-thinning medication.
St. Jude Medical reveals the Japanese launch of its Ilumien Optis device, designed to indicate the state and severity of coronary lesions during stent procedures.
St. Jude Medical (NYSE:STJ) said its launched the Ilumien Optis device in Japan, calling it the only medical device on the market to combine fractional flow reserve and optical coherence tomography technology to allow doctors to evaluate the state and severity of coronary lesions.
Veteran cardiologist and patient safety advocate Dr. Robert Hauser tells MassDevice.com about his new vision for healthcare surveillance, his long struggle to spur change at the FDA and what FDA regulators can learn from aviation regulation.
Veteran cardiologist Dr. Robert Hauser is eager for change, even if he has to go straight to Capitol Hill himself to make it happen.
The patient safety advocate and vocal critic of the FDA announced at this year's American College of Cardiology conference that he's working on a proposal to fundamentally change the way federal regulators monitor medical devices and drugs once they hit the market.
Researchers uncover another potential platform for deep brain stimulation, treating patients with chronic and treatment-resistant anorexia.
In what some are calling "a world 1st," researchers reported some success in treating severe anorexia patients via implanted electrodes that delivered electrical energy to the regions of the brain associated with emotion.
The study enrolled 6 patients to receive the experimental treatment, reporting that 3 of the 6 achieved weight gain and 4 of the 6 reported changes in mood, anxiety, control over their urges to binge and purge and other symptoms associated with anorexia.
St. Jude Medical pushes for action on a pair of lawsuits against Volcano over laser sales and fractional flow reserve patents.
